Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126191721 | 12619172 | 1 | I | 20160322 | 20160718 | 20160803 | 20160803 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-48154BP | BOEHRINGER INGELHEIM | 58.55 | YR | M | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126191721 | 12619172 | 1 | PS | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | 20579 | .4 | MG | CAPSULE | ||||||||
126191721 | 12619172 | 2 | C | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 0 | 50 | MG | TABLET | ||||||||
126191721 | 12619172 | 3 | C | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 0 | 300 | MG | TABLET | ||||||||
126191721 | 12619172 | 4 | C | PREGABALIN. | PREGABALIN | 1 | Unknown | 0 | 100 | MG | CAPSULE | ||||||||
126191721 | 12619172 | 5 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | 0 | 800 | MG | TABLET | ||||||||
126191721 | 12619172 | 6 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | Unknown | 0 | 200 | MG | TABLET | ||||||||
126191721 | 12619172 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 0 | 25 | UG | TABLET | ||||||||
126191721 | 12619172 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | 20 | MG | TABLET | ||||||||
126191721 | 12619172 | 9 | C | PHENYTOIN. | PHENYTOIN | 1 | Unknown | EXTENDED RELEASE (ER) | 0 | 100 | MG | CAPSULE | |||||||
126191721 | 12619172 | 10 | C | SENNOSIDES-DUCOSATE SODIUM | 2 | Unknown | STRENGTH: 8.6-50MG | 0 | TABLET | ||||||||||
126191721 | 12619172 | 11 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | 0 | 25 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126191721 | 12619172 | 1 | Product used for unknown indication |
126191721 | 12619172 | 2 | Product used for unknown indication |
126191721 | 12619172 | 4 | Product used for unknown indication |
126191721 | 12619172 | 5 | Product used for unknown indication |
126191721 | 12619172 | 6 | Product used for unknown indication |
126191721 | 12619172 | 7 | Product used for unknown indication |
126191721 | 12619172 | 8 | Product used for unknown indication |
126191721 | 12619172 | 9 | Product used for unknown indication |
126191721 | 12619172 | 10 | Product used for unknown indication |
126191721 | 12619172 | 11 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126191721 | 12619172 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126191721 | 12619172 | 1 | 20160322 | 0 |